LFR
LSTA icon

Lehman Financial Resources’s Lisata Therapeutics LSTA Stock Holding History

Lehman Financial Resources’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1
Closed – – 216
2015
Q3 		$0 Hold
1
– – ﹤0.01% 472
2015
Q2 		$0 Buy
+1
New +$372 ﹤0.01% 435

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lehman Financial Resources's LSTA Position: Q4 2015 in Review

Lehman Financial Resources sold out of Lisata Therapeutics (LSTA) in Q4 2015, closing a stake of 1 share.

Lehman Financial Resources first reported a position in LSTA in Q2 2015 and held it in 2 quarters. The position peaked at $0 in Q3 2015. 47 funds tracked by Wall St. Rank hold LSTA as of Q4 2015.

  • Lehman Financial Resources reported no remaining Lisata Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Lehman Financial Resources sold 1 Lisata Therapeutics share in Q4 2015.
  • Lehman Financial Resources first reported a position in Lisata Therapeutics in Q2 2015 and held it in 2 quarters.
  • Lehman Financial Resources's Lisata Therapeutics position peaked at $0 in Q3 2015.
  • 47 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2015.

Based on Lehman Financial Resources's 13F filing for Q4 2015, filed 17 Feb 2016.